Rapid-Progressive Glomerulonephritis - Prof. de Groot (Offenbach)

preview_player
Показать описание
⇓ ⇓ ⇓ ⇓ ⇓ ⇓ ⇓ ⇓ ⇓ ⇓ WEITERE INFOS UND LINKS ⇓ ⇓ ⇓ ⇓ ⇓ ⇓ ⇓ ⇓ ⇓ ⇓

Frau Prof. Dr. Kirsten de Groot (Offenbach) diskutiert Pathophysiologie, Diagnostik und Therapie der Rapid-progressiven Glomerulonephritis (RPGN) mit Fokus auf die ANCA-assoziierte Vaskulitis.

Im Video diskutierte Studie:

ANCA Disease: Where Is This Field Heading?
RJ Falk and JC Jennette, JASN, 2010

Standardized Neurologic Evaluations of 128 Patients With Wegener Granulomatosis
K de Groot et al., Arch. Neurol. 2001

ANCA-Associated Vasculitis: Core Curriculum 2020
D Geetha and JA Jefferson, AJKD 2019

Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis
X Bossuyt et al., Nature Reviews Rheumatology 2017

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
M Walsh et al., NEJM 2020

Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial FREE
RB Jones et al., Ann Rheum Dis 2019

ituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
L Guillevin et al., NEJM 2014

Avacopan for the Treatment of ANCA-Associated Vasculitis
DRW Jayne et al., NEJM 2021

Übersicht über KDIGO Leitlinien GN 2021 von Professor Kirsten de Groot unter:

Рекомендации по теме